Iovance grants stock options covering 175,840 shares to 22 new employees
IOVA•Iovance Biotherapeutics granted inducement stock options covering 175,840 shares to 22 new, non-executive employees on Nov. 19, 2026. The options vest over three years, subject to continued employment.
1. Option grants
Iovance Biotherapeutics granted inducement stock options covering 175,840 shares to 22 new, non-executive employees on Nov. 19, 2026. One-third of the options vest on the first anniversary of each employee's start date, with the remainder vesting in eight quarterly installments over the following two years; vesting is subject to continued employment.




